Marketwatch slrx

Author: mbrt

August undefined, 2024

Web19 mrt. 2024 · Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers … Web4 nov. 2024 · Salarius (SLRX) delivered earnings and revenue surprises of 11.11% and -100.00%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Salarius Pharmaceuticals, Inc. (SLRX) - Yahoo Finance

WebStock Price Target SLRX Advertisement Related Links: Options Overview Research & Ratings Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and... WebDownload SLRX Data Salarius Pharmaceuticals Inc. Price Data MarketWatch Download Salarius Pharmaceuticals Inc. stock data: historical SLRX stock prices from … jeff foust fort wayne

SLRX News Today Why did Salarius Pharmaceuticals stock go up …

WebBaudax Bio, Inc. (BXRX) Stock Price, News, Quote & History - Yahoo Finance Baudax Bio, Inc. (BXRX) NasdaqCM - NasdaqCM Delayed Price. Currency in USD Follow 2W 10W 9M 1.6000 -0.0200 (-1.23%) As... WebGet the latest Salarius Pharmaceuticals Inc (SLRX) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebSLRX is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (01/31/23) Shares Sold Short 101,086 Change from Last 37.70% Percent of Float 5.20% Stock... oxford crest eagleby

Salarius Pharmaceuticals, Inc. (SLRX) - Stock Analysis

Marketwatch slrx

Salarius Pharmaceuticals - SLRX - Stock Price Today - Zacks

Web17 mrt. 2024 · SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list Create SLRX Alert After Hours Last Updated: Mar 17, 2024 7:50 p.m. EDT Delayed quote $ 2.0700 … SLRX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq SLRX U.S.: … Salarius Pharmaceuticals Inc. company facts, information and financial ratios … Salarius Pharmaceuticals Inc. Annual cash flow by MarketWatch. View SLRX net … Web3 apr. 2024 · Salarius Pharmaceuticals (SLRX) (Real Time Quote from BATS) $1.75 USD -0.16 (-8.38%) Updated Apr 3, 2024 03:04 PM ET Add to portfolio Zacks Rank: Style Scores: NA Value NA Growth NA Momentum...

Did you know?

WebIn this SLRX stock guide, we'll address key questions about SLRX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar. Here is what you'll be able to find in this guide: Earnings and Dividends: earnings, … Web28 okt. 2024 · This biotech drug developer is expected to post quarterly loss of $0.09 per share in its upcoming report, which represents a year-over-year change of +10%. Revenues are expected to be $0.6 million,...

Web16 dec. 2024 · Thinly traded nano cap Salarius Pharmaceuticals (NASDAQ: SLRX) is up 12% premarket on increased volume in reaction to Fast Track designation in the U.S. for lead candidate seclidemstat for the... WebSLRX - Salarius Pharmaceuticals Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.

Web10 mrt. 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Salarius Pharmaceuticals stock is Buy based on the current 1 buy rating for SLRX. The average twelve-month price prediction for Salarius Pharmaceuticals is $100.00 with a high price target of $100.00 and a low price target of $100.00. Web31 mrt. 2024 · (SLRX) Toevoegen aan lijst Rapport Geschatte financiële gegevens (e) Meer Financiële cijfers Bedrijfsprofiel Salarius Pharmaceuticals, Inc. is een biofarmaceutisch bedrijf in een klinische fase, dat zich richt op de ontwikkeling van effectieve behandelingen voor kankers met een grote, nog niet behandelde medische behoefte.

Web13 jun. 2024 · SLRX - Salarius Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 …

WebSalarius Pharmaceuticals, Inc. (SLRX) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 4 hours 35 minutes Dow Futures +50.00 Nasdaq Futures +1.75 Russell 2000 Futures +1.50... jeff foust excavatingWeb31 mrt. 2024 · Salarius Pharmaceuticals - SLRX - Stock Price Today - Zacks Salarius Pharmaceuticals (SLRX) (Delayed Data from NSDQ) $1.91 USD -0.11 (-5.45%) Updated Mar 31, 2024 03:43 PM ET After-Market:... jeff fowler obituaryWebEarnings Summary For their last quarter, Salarius Pharmaceuticals (SLRX) reported earnings of -$2.83 per share, missing the Zacks Consensus Estimate of -$2.07 per share. This reflects a negative... oxford crest bundambaWeb4 jun. 2024 · Salarius Pharmaceuticals (NASDAQ: SLRX) shares are getting an over 14% boost as it prepares to present data at the American Society of Clinical Oncology (ASCO) annual meeting. Q&K International... jeff fowler assessment toolsWeb18 nov. 2024 · U.S. markets close in 2 hours 20 minutes Dow 30 +141.30 Nasdaq 12,059.04 -25.31(-0.21%) Russell 2000 +15.87(+0.90%) Crude Oil Gold (+0.78%) SNDL Inc. … oxford crest gympie gardens jeff fowler parenting assessmentWebSalarius Pharmaceuticals Inc. Quarterly balance sheet by MarketWatch. View all SLRX assets, cash, debt, liabilities, shareholder equity and investments. oxford crest raceview